These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Generic vs. proprietary otic drops. Hotmes WF; Cunningham JD; Alford E Trans Pa Acad Ophthalmol Otolaryngol; 1989; 41():859-60. PubMed ID: 2561028 [No Abstract] [Full Text] [Related]
3. Tympanostomy tubes and otic drops. Meyerhoff WL; Morizono T; Wright CG; Shaddock LC; Shea DA; Sikora MA Laryngoscope; 1983 Aug; 93(8):1022-7. PubMed ID: 6308368 [TBL] [Abstract][Full Text] [Related]
4. Ototoxicity of otic drops applied to the middle ear in the chinchilla. Wright CG; Meyerhoff WL Am J Otolaryngol; 1984; 5(3):166-76. PubMed ID: 6331211 [TBL] [Abstract][Full Text] [Related]
5. [Clinically presumptive toxicity of various ear-drops]. Goffinet M Acta Otorhinolaryngol Belg; 1977; 31(6):585-90. PubMed ID: 202140 [No Abstract] [Full Text] [Related]
6. [Influence of local application of isoptomax eye drops on neuromuscular transmission]. Koenig A; Ohrloff C Klin Monbl Augenheilkd; 1981 Aug; 179(2):109-12. PubMed ID: 6290749 [TBL] [Abstract][Full Text] [Related]
7. Cochleotoxicity of otic drops in the chinchilla: comparative study of Bestron and Cortisporin. Ikeda K; Morizono T; Juhn SK Am J Otol; 1991 Nov; 12(6):429-34. PubMed ID: 1805633 [TBL] [Abstract][Full Text] [Related]
8. Is there an ototoxicity risk from Cortisporin and comparable otic suspensions? Distortion-product otoacoustic emission findings. Berenholz LP; Rossi DL; Lippy WH; Burkey JM Ear Nose Throat J; 2012 Mar; 91(3):106-35. PubMed ID: 22430335 [TBL] [Abstract][Full Text] [Related]
10. [Granulation tumor of the orbit following ointment treatment of the maxillary sinus]. Brusis T HNO; 1984 Dec; 32(12):511-4. PubMed ID: 6099348 [TBL] [Abstract][Full Text] [Related]
11. Simultaneous contact allergy to neomycin, bacitracin, and polymyxin. Grandinetti PJ; Fowler JF J Am Acad Dermatol; 1990 Oct; 23(4 Pt 1):646-7. PubMed ID: 2172331 [TBL] [Abstract][Full Text] [Related]
12. Diffuse cutaneous hypersensitivity reaction after dexamethasone/polymyxin B/neomycin combination eyedrops. Baldinger J; Weiter JJ Ann Ophthalmol; 1986 Mar; 18(3):95-6. PubMed ID: 3008629 [TBL] [Abstract][Full Text] [Related]
13. Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa. Schwartz RH Curr Med Res Opin; 2006 Sep; 22(9):1725-36. PubMed ID: 16968576 [TBL] [Abstract][Full Text] [Related]
17. Toxicity of ototopical drugs: animal modeling. Morizono T Ann Otol Rhinol Laryngol Suppl; 1990 Jun; 148():42-5. PubMed ID: 2112363 [TBL] [Abstract][Full Text] [Related]
18. [Panotile: new ear drops. Apropos of 50 cases]. Bébéar JP; Vincey P Rev Laryngol Otol Rhinol (Bord); 1977; 98(11-12):633-6. PubMed ID: 205934 [No Abstract] [Full Text] [Related]
19. Comparative efficacy and tolerability of two ointment and suppository preparations ('Uniroid' and 'Proctosedyl') in the treatment of second degree haemorrhoids in general practice. Smith RB; Moodie J Curr Med Res Opin; 1988; 11(1):34-40. PubMed ID: 2838221 [TBL] [Abstract][Full Text] [Related]
20. Use of Cortisporin Otic Solution in phenol nail surgery. Anton-Athens V; Ketai DL J Am Podiatr Med Assoc; 1985 Jan; 75(1):31-3. PubMed ID: 2984406 [No Abstract] [Full Text] [Related] [Next] [New Search]